New 25-Minute bone scan could spot cancer faster with less radiation
NCT ID NCT04157166
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new 3D bone scan camera (VERITON-CT) that takes only 25 minutes and uses less radiation than standard scans. Researchers compared it to conventional 2D scans in 146 people with suspected or known bone metastases. The goal was to see if the new method could accurately detect and classify cancer spread in the bones.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to faster, more accurate bone scans with lower radiation for people with suspected cancer spread.
- What could go wrong
- This is a completed imaging comparison study, not a treatment trial. The new camera may not prove better in all cases, and results may not apply to all hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Médecine Nucléaire - CHRU de Nancy-Brabois
Vandœuvre-lès-Nancy, 54511, France
-
Veronique Roch
Vandœuvre-lès-Nancy, 54511, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Preventive radiation may stop bone events before they start — a trial puts it to the test
- Can a new capsule ease bone metastasis pain without opioids?
- Hip muscle repair method may improve walking after bone cancer surgery
- New model aims to predict jaw bone disease before it strikes
- Could removing the primary tumor boost survival in stage IV breast cancer with Bone-Only spread?
- Can bone markers predict survival in lung cancer patients?